ANGIOTENSIN-CONVERTING ENZYME GENE POLYMORPHISM., THE CLINICAL COURSE AND THE STRUCTURAL AND FUNCTIONAL STATE OF THE HEART AT THE UZBEK PATIENTS WITH DILATED CARDIOMYOPATHY
https://doi.org/10.38109/2225-1685-2014-2-63-70
Abstract
Background. The study of genes polymorphism of angiotensinconverting enzyme (ACE) and their contribution to development and clinical course of dilated cardiomyopathy (DCM), and the possibility of early diagnostics and differentiated pharmacotherapy in early and advanced stages of the disease, is a promising new area of medical genetics and cardiology research. The aim. To study the genes polymorphism of angiotensinconverting enzyme (ACE) at DCM patients in the Uzbek population, to reveal the feature of heart remodeling depending on a genotype, and also an estimation of Lisinopril efficiency at these patients. Material and methods. It has been surveyed 102 DCM patients of the Uzbek nationality, with II-IV classes by NYHA. Besides an estimation of the clinical status (test of six-minute walking, clinical status estimation score (in Mareev modification) it has been spent 12-led ECG, EchoCG, Holter ECG, rentgenkardiometriya. These data were analyzed depending on the revealed genotype. Results. For the first time we have studied the genes polymorphism at Uzbek DCM patients. It has been showed feature of clinical and instrumental data depending on genotype, and also revealed unfavorable types of gene inheritance. It has been noted a high efficiency of Lisinopril application at DCM patients depending on the ACE- genes polymorphism.
About the Authors
R. D. Kurbanov
Republican Specialized Center of Cardiology Ministry of Health of Uzbekistan
Russian Federation
Russian Federation
N. A. Kurbanov
Republican Specialized Center of Cardiology Ministry of Health of Uzbekistan
Russian Federation
Russian Federation
T. A. Abdullayev
Republican Specialized Center of Cardiology Ministry of Health of Uzbekistan
Russian Federation
Russian Federation
References
1. Shelling P., Fisher H., Ganten D. Angiotensin and cell growth: a link to cardiovascular hypertrophy. Br Heart J. 1993; 49: 568-573.
2. Danser A., Schalekamp M., Bax W.A. et al. Effect of deletion/ insertion polymorphism. Circulation. 1995; 92: 1387-1388.
3. Мустафина О.Е., Туктарова И.А., Бикмеева Т.Р. Исследование инсерционно-делеционного полиморфизма гена ангиотензин-превращающего фермента в популяциях Волго-Уральского региона. Ж. Генетика. 2001; 37(2): 1-5.
4. Lee E.J. Population genetics of the angiotensin-converting enzyme in Chinese. Brit J Clin Pharmacol. 1994; 37: 212-214.
5. Беленков Ю.Н., Мареев В.Ю. Принципы рационального лечения сердечной недостаточности. - М., 2000.-266с.
6. Guyatt G.H., Sullivan M.J.,Tompson P.J. et al. The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure. Can Med Assoc J.1985; 132 (8): 919-923
7. Richardson P., McKenna W., Bristow M. et al. Report of the 1995 World Organization. International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies. Circulation. 1996; 93: 841-842.
8. Raynolds M.V., Bristow M.R., Bush E.W. et al. Angiotensinconverting enzyme DD genotype in patients with ischaemic or idiopathic dilated cardiomyopathy. Lancet. 1993; 342: 10731075.
9. Montgomery H.E., Keeling P.J., Goldman J.H., Humphries S.E. at al. Lask of association between the insertion/deletion polymorphism of the angiotensin-converting enzyme gene and idiopathic dilated cardiomyopathy. J Am Coll Cardiol. 1995; 25: 1627-1631.
10. Brandt-Pohlmann M., Pohle K., Beyer-Finkler E. et al. Polymorphism of angiotensin-converting enzyme gene in patients with idiopathic dilated cardiomyopathy. XIX Congress of the European Society of Cardiology. August 24-28, 1997-Stokholm, Sweden.
11. Iwai N., Ohmichi N., Nakamura Y. еt al. DD genotype of the angiotensin-converting enzyme gene is a risk factor for left ventricular hypertrophy. Circulation. 1994; 90: 2622-2628.
12. Pontermoni M., Sofia A., Tirotta A. et al. The deletion polymorphism of the angiotensin-converting enzyme gene is associated with target organ damage in essential hypertension. J Am. Soc Nephrol. 1996; 7: 2550-2558.
13. Johnson D.B., Foster R.E., Kirk K. et al. Angiotensin-Converting Enzyme Genotype Does Not Influence Myocardial Hypertrophy After Acute Myocardial Infarction. In: Congress of the European Society of Cardiology, 21-th: Abstract. Stockholm 1997; 970.
14. Skudicky D., Norton G., Candy G. et al. DD genotype of the angiotensin-converting enzyme gene in associated with a greater improvement of left ventricular function in patients with idiopathic dilated cardiomyopathy treated with ACE-inhibitors. In: Congress of the European Society of Cardiology, 21-th: Abstract. Stockholm 1997; 1677.
15. Andersson B., Sylven C. The DD genotype of the angiotensinconverting enzyme gene is associated with increased mortality in idiopathic heart failure. J Am Coll Cardiol 1996; 28: 162-167.
16. Fazio S., Sabatini D., Capaldo B. et al. A preliminary study of growth hormone in the treatment of dilated cardiomyopathy. N Engl J Med. 1996; 334-809.
17. Rigat B., Hubert C., Alhenc-Gelas F. et al. An insertion/deletion polymorphism in the angiotensin-I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990; 86: 1343-1346.
18. Moe G.W., Stewart D.J. Role of the renin-angiotensin system in the pathophysiology of the heart failure. Medicographia. 1997; 19: 18-22.
19. Ribichini F., Steffening G., Dellavalle A. et al. Plasma activity and insertion/deletion polymorphism of angiotensin I-converting enzyme gene. A major risk factor and a market of risk for coronary stent restenosis. Circulation. 1998; 97: 147-154.
20. Pfeffer J.M. Pfeffer M.A., Braunwald E. Influence of chronic captopril therapy on the infarcted left ventricle of the rats. Circ. Res. 1985; 57: 84-95
21. Dzau V. Tissue renin-angiotensin system in myocardial hypertrophy and failure. Arch Intern Med 1993; 153: 937-942.
22. Bell D.M., Rutledge D.R., Pepine C.J. Association of the Insertion/ Deletion Polymorphism of the Angiotensin Converting Enzyme Gene and Angiotensin Converting Enzyme Inhibitor Cough in Patients with Congestive Heart Failure. In: Congress of the European Society of Cardiology, 21-th: Abstract. Stockholm 1997; 976.
23. Терещенко C.H., Джаиани Н.А., Моисеев В.С. Генетические аспекты хронической сердечной недостаточности. Тер. Арх. 2000; 4: 75-77.
Review
For citations:
Kurbanov R.D., Kurbanov N.A., Abdullayev T.A. ANGIOTENSIN-CONVERTING ENZYME GENE POLYMORPHISM., THE CLINICAL COURSE AND THE STRUCTURAL AND FUNCTIONAL STATE OF THE HEART AT THE UZBEK PATIENTS WITH DILATED CARDIOMYOPATHY. Eurasian heart journal. 2014;(2):63-70. (In Russ.) https://doi.org/10.38109/2225-1685-2014-2-63-70
Views:
407
Email this article 
